We have been bullish on Piramal on this blog for quite some time now. We decided to put up the performance of these buys against the SENSEX and NIFTY since our purchase. Until recently, Piramal Enterprises was our biggest holding in the Portfolio.
During the Fiscal debt cliff uncertainty last year, we bought one stock called Company A in the US that is the biggest portion of the portfolio and we are also invested in another Health Care company in India that is slightly bigger than our investment in Piramal.
However, we continue to believe that Piramal is still undervalued and the original thesis still holds good and we have listed below the performance against the Indian indices. Piramal has outperformed the Healthcare Index, Sensex and Nifty. We do not expect any big improvement in the Q3 results on Feb 2013. We are not counting on extraordinary performance to fuel returns in the long run.
During the Fiscal debt cliff uncertainty last year, we bought one stock called Company A in the US that is the biggest portion of the portfolio and we are also invested in another Health Care company in India that is slightly bigger than our investment in Piramal.
However, we continue to believe that Piramal is still undervalued and the original thesis still holds good and we have listed below the performance against the Indian indices. Piramal has outperformed the Healthcare Index, Sensex and Nifty. We do not expect any big improvement in the Q3 results on Feb 2013. We are not counting on extraordinary performance to fuel returns in the long run.
No comments:
Post a Comment